Introduction
Asthma mortality and morbidity are unacceptably high. Many deaths and much unnecessary morbidity have been associated with over-reliance on bronchodilators, inadequate medical supervision, underuse of inhaled and oral corticosteroid treatment, and a failure to make objective measurements of the severity of asthma (1). In studies on deaths from asthma involving retrospective analysis of action taken during an acute exacerbation (2-8) the most important, consistent theme in such deaths was suboptimal management of the final attack due to an inability to recognize the severity of the attack and a delay in seeking medical help.
An increasing number of people with chest problems are using home nebulizer therapy. Opinion is divided on the safety of such widespread use (9) and there are anecdotal instances of misuse of this therapy (9). Some studies have suggested that more widespread home nebulization could reduce mortality (2,lO) . An opposing view is that patients may place excessive confidence in a piece of equipment which appears to be 'technical', as distinct from the less visually dramatic inhalers. Grant (3)' suggested that nebulizers could result in people over-relying on their bronchodilators and failing to call for further medical assistance; this might lead to death.
The suggestions of many authors (2-8, 10-13) on nebulizer use are reinforced by the British Thoracic Society (BTS) Asthma Guidelines (14) which advocate greater participation of the parent or patient in the management of asthma. The BTS guidelines for supervision of people receiving nebulized bronchodilators at home state: 1. Oral and written instruction should be given to the patient on the method and frequency of use, the action to be taken in the event of worsening asthma, and when to attend for follow-up.
2. Supervision should normally entail attendance at an asthma clinic or home visits by a trained asthma nurse or physiotherapist.
3. Supervision should include evaluation of peak expiratory flow, monitoring of prescriptions, and twice yearly servicing of the compressor.
Within the country, many asthma specialists now operate effective systems for loaning patients nebulizer units, giving accompanying education packages. However, it is likely that some people purchasing their own nebulizers do not become involved in such a support scheme. This study comprises two parts. Firstly, it audits the Southampton General Hospital Paediatric Asthma Clinic nebulizer instruction package which contains practical demonstration and written information on nebulizer use and the recognition and management of deteriorating asthma.
Secondly, it comprises a comparison between two populations of nebulizer users on the level of supervision and instruction on nebulizer use for worsening asthma which they feel they received. The two populations were drawn from across the U.K. and had purchased their machines directly from a manufacturer?.
Methods
The survey took the form of a postal questionnaire. The study population was grouped as follows.
HOSPITAL AUDIT Ninety children with home nebulizers attending Southampton General Hospital Paediatric Asthma Clinic (76 units on loan and 14 privately purchased). This group was designated SGHchild; 'SGHC'.
NATIONAL SAMPLES
Two hundred asthmatic children whose parents had purchased their nebulizers directly from the manufacturers.
This group was designated United Kingdom-child; 'UKC'. Two hundred asthmatic adults who had purchased their nebulizers directly from the manufacturers. This group was designated United Kingdom-adult; 'UKA'. Names and addresses for the two national samples were obtained from the purchase records of the manufacturer 'Medic Aid Ltd'; all those contacted were believed to have asthma. The questionnaire was produced in two formats; one directed to adult purchasers with asthma, the other for parents of children with asthma (16 years of age and younger). Non-responders were sent one further copy of the questionnaire.
Question style was initially piloted on SGH paediatric patients with loaned nebulizers who had respiratory disorders other than asthma (e.g. cystic fibrosis). Medical jargon was avoided. Subjects were asked to state their diagnosis; those found not to have asthma had question responses coded as 'not applicable' for questions relating to asthma tMedic Aid Limited, Chichester, U.K.
management.
All responses given by the subjects reflect the information they feel they received. Unfortunately, it was not possible to discover what information their doctor felt they had been given. The majority of the questions were multiple choice format, with room for additional comments where appropriate.
People's responses to an acute attack were assessed using a series of scenarios, with questions on appropriate
responses. Two open questions were used to discover how the patient's respiration and appearance would change during an exacerbation. The answers were then interpreted by the investigator to identify seven important factors, with an eighth section for other relevant features.
Data processing was performed using SPSS4. The chi-squared test was used to compare the groups; a probability value of less than 0.05 was considered significant. Where tables contained small numbers, Fisher's Exact Test was used, calculating l-tailed P values which were then doubled.
Approval for the trial was granted by Southampton Joint Ethics Committee.
Results

HOSPITAL AUDIT (TABLES I AND 2)
There was a response rate of 77% (69) amongst the SGH children's families. Of these, 99% had received initial instruction on nebulizer use, were satisfied with the information package supplied and felt confident about using their nebulizers. A peak flow meter was used at home by 80% of 5 and 6 year olds and 86% of the older children to monitor their condition. Cyanosis, wheeze/cough, laboured breathing and increased respiratory rate were identified by 57-88% of families as possible identifying features of an acute respiratory attack, 54% mentioning four or more features of respiratory distress. They were all aware of the '4 h rule' which states that unsupervised repetition of bronchodilators is once every 4 h while more frequent usage should lead one to seek medical assistance and take oral steroids. Should the nebulizer fail to produce relief, 99% possessed a crisis plan; 2% of whom would immediately commence oral steroids, the rest stating they would seek medical assistance with or without commencing oral steroids.
NATIONAL GROUPS -COMPARISON BETWEEN ADULTS AND CHILDREN
One hundred and twelve children's families (56%) replied to the questionnaire, 95% had childhood asthma and one child had cystic fibrosis. The majority of children (70%) using nebulizers were aged below 5 years, the other 30% equally divided between children aged 5 or 6 years, and children older than 6 years.
Responses were received from 116 adults (58%); 67% had asthma and 28% had chronic obstructive airways disease. Pattern of care varied in that more adults (55%) than children (33%) were treated in the community alone, while most children had care shared between their GP and hospital (47% children and 39% adults). The remaining 20% of children and 4% of adults were managed by their hospital. Table 1 gives details of instruction which the patients felt they received about their nebulizer. Most patients had some form of initial instruction; mainly from a doctor, nurse or physiotherapist. Only approximately one-quarter received follow-up supervision. The form which initial instruction took varied considerably.
The majority of respondents were satisfied with their initial instruction.
Some dissatisfied people commented that they wanted someone local to whom they could refer in times of difficulty. Others requested written information.
Interestingly, most people felt confident about using their nebulizerthis confidence perhaps not always being appropriate in relation to their medical knowledge. When asked whether the patient felt a nebulizer could in any way lead to poor treatment of an attack, children seemed more alert to this than adults. Of those who felt it could, the majority stated over-reliance or overunder-dose as their concern. One person mentioned the temptation of not 'bothering' with prophylaxis. The following three areas relating to asthma exacerbations were examined: the patient's ability to recognize a severe respiratory attack, their knowledge of appropriate instruction for treating such an attack and to ascertain whether they had a crisis plan to follow should the nebulizer fail to produce relief.
Ability to recognize a severe respiratory attack (Table 2) Only 33% of adult patients stated that they possessed a peak flow meter and would use it to assess their tightness. The number of children using a flow meter varied with age. Significantly more of the children aged over 7 years used meters when compared with the adults (P<O.OOl). All those who had a meter at home understood what it was for; 5% who did not have a home meter also knew its purpose.
Scoring of the open questions asking participants to describe how their appearance and behaviour would alter during an attack revealed that the parents reported relatively frequently on physical signs listed in the table, while the adults did not, except for 'laboured' breathing and less specific features ('other').
Knowledge of appropriate instruction for treating an acute attack (Table 2) All respondents were prescribed nebulized bronchodilator therapy. The majority of both groups understood the '4 h rule' for safe maximal repetition of bronchodilator therapy at home (34 hourly in some cases). However, the parents of one of the UKC population was happy to give it hourly. Crisis plan ifnebulizer fails to produce relief (Table 2) The need for patient education and supervision When asked whether people had a contingency concerning home nebulization has been stressed plan should they fail to derive benefit from the (1,12,13), yet this survey reinforces the idea that such follow-up monitoring and reinforcement may be lacking. Amongst the patients who purchased their own units, there was a very poor level of follow-up supervision. Only 25% had follow-up supervision.
Clear instruction on use of the nebulizer is produced by the manufacture& which states the units: 'should only be used by prescription or under the direction of a doctor' and medical instruction should be sought on how to take the nebulizer treatment. These statements are further echoed in the BTS guidelines (14) and National Asthma Campaign booklet (15) on nebulizer use which includes basic guidelines for home nebulizer use. The booklet states that further information must be gleaned from medical personnel who should write down instructions on treatment and action plans for worsening asthma symptoms. Bendefy (16) states that written as well as verbal instructions are essential for safe home nebulization. The recently published GRASSIC study (17) found that patients valued most highly the sections of their educational booklets that gave objective advice about the action to be taken when patients felt breathless, the most popular topic being 'what to do in a severe asthma attack'. Again, it appears that education about asthma in general may not be of $Medic Aid Limited, Chichester, U.K.
great benefit; what is effective is information focusing on the management of symptoms. Responses in this study suggest that our hospital group has derived benefit from their package of written and verbal information.
However, it is likely that the 21 nonresponders to the questionnaire have poorer knowledge than the 69 who replied. A crisis plan was not felt to have been provided for one-quarter of the UKC population and two-thirds of the UKA population. In view of this finding, in addition to the practical information issued by manufacturers, each nebulizer purchased should include a medical card containing a table for treatment plans, signs of respiratory distress and action plan (Fig. 1) to be deleted and completed appropriately for the patient. Controlled, prospective evaluation of the effectiveness of such a card, both in terms of affecting perceived knowledge and actual action in a crisis, should be undertaken.
In the two national groups, the relatively high level of satisfaction with initial instruction received and general high level of confidence concerning nebulizer use is not borne out by the responses to medical questions. Perhaps patients are satisfied with knowing how, rather than knowing when, to deliver nebulized therapy. A clinical impression is that because one can see and hear them working and because larger doses of treatment are administered in nebulizers, they are often viewed by patients as panaceas, and may instill the patient with a false sense of security. The variety of reasons why people purchase nebulizers range from an attempt to avoid occasional hospital admissions, to facilitation of administration of regular therapy. The purpose of this paper is not to assess the appropriateness of this form of treatment delivery. Nevertheless, all who have one must be instructed to respond appropriately in the event of an emergency.
Subjective assessment is said to be a poor indicator of airway obstruction (18). Recent work suggests that 60% of patients with asthma are poor discriminators of asthma (19). It is therefore essential that simple peak flow meter recording is used for home monitoring. In children, educational efforts involving concise management plans (20) can influence the selfmanagement behaviour of parents, and many parents find home peak flow monitoring helpful in recognizing severe asthma attacks (21). The small number of adults (33%) using meters is alarming, but concurs with the national audit of asthma attacks in Britain in 1991-1992, which found that only 29% of patients had their own peak flow meter (22).
Fletcher (7) and Buranakul (8) stated that parents must be educated to recognize the danger signs of severe respiratory distress. Parents more frequently recognized such signs than the adult patients. It is obviously harder for the adult sufferers to be aware of changes occurring in themselves, compared with parents who are observing their child. This again emphasizes the need for peak flow meter monitoring.
A useful criterion for hospital admission is failure to respond to two doses of bronchodilators administered 4 h apart (23). Failure to respond or poor response to the usual dose of inhaled p-agonist is probably the most important symptom of deterioration and indicates the need for immediate assessment and change of therapy (1, 8, 24, 25) . The majority of both groups stated they would use bronchodilators 4 h apart, but one-fifth of the U.K. population is a worrying proportion to be unaware of this rule. It is interesting to note that children with asthma whose parents had bought a nebulizer were more likely to be seen by a Consultant Paediatrician, to be given a peak flow meter and appropriate advice on the use of their nebulizer than adults.
It has been stated (2-7,10,11) that possession of nebulizers has led to doctors overlooking the subject's requirement for further intervention such as oral steroids. Some comments in the survey reinforce this idea; 'Doctors feel you have the same amount of treatment available as the GP' 'Ambulancemen, particularly non-paramedics seem to think all has been done and that I'll get over it on my own when they see the nebulizer'.
Oral steroids have been described as 'accepted practice' in management of adult asthmatics but some paediatricians have been reluctant to apply this to children (11). A relatively small number of people in any category of our survey commented on use of home oral steroids. Although early commencement is essential, their prescription must be judicious and accompanied by written instruction.
This survey must confine itself to assessing the appropriateness of knowledge that responders believe they have received concerning nebulizer use; it cannot comment on the actual behaviour of participants in times of crisis. Nor should the findings of these nebulizer owners be applied to all home users, many of whom one hopes will be involved in specialist asthma loan support schemes. In general, we believe that if a patient is considered to need a home nebulizer then they should be supervised by a clinic capable not only of providing appropriate education and training, but also a regular maintenance service. Nebulizers should be serviced twice yearly (14) . However, concerns about inadequate education on home nebulizer use are still justified today. It is unwise to assume that the medical aspect of home therapy can be directed and assessed by all doctors (26), yet many doctors are put in the position of being the only source of information for the patient. Nor is it correct to assume that people know how to use a nebulizer safely. Inclusion of a card (Fig. 1) which could be located in the nebulizer casing of all manufactured nebulizers would place the onus on each nebulizer purchaser to ensure that it is completed by the doctor or asthma specialist and would raise questions in the purchaser's mind on the information he needs to absorb. Used sensibly, nebulizers may play a vital role in reducing asthma morbidity and hospital admissions.
